CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Repligen soars 16% after blockbuster earnings, FY25 guidance upgrade

EarningsPositive
AI Analysis

Summary

Repligen reported blockbuster earnings and raised FY25 guidance, driving a 16% stock price increase.

Financial Highlights

Guidance

upgraded for FY25

Importance:5/10
Sentiment:
0.80
earningsguidance_raisestock_performance
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 28, 2026 6:49 PM

Read Original